Aeterna Zentaris, Inc. (AEZS) Obtains FDA Investigational New Drug Approval for Leading Bladder Cancer Indication
Aeterna Zentaris Inc. is an innovative developer of oncology and endocrine therapies like Cetrotide®, which was the very first luteinizing…